Saturday, 28 March 2026
12:00 - 3:30 pm
Sheraton Towers
Rapid advances in syndromic molecular diagnostic panels are reshaping the management of infectious diseases, enabling broad pathogen detection from a single specimen within hours and supporting earlier, more targeted therapy.
This symposium explores the clinical impact of these high-cost technologies across common infectious syndromes, highlighting their role in antimicrobial stewardship, timely decision-making and patient outcomes.